Niagen Bioscience, Inc. (NAGE) — Financial Flexibility Index
Niagen Bioscience, Inc. (NAGE) has a Financial Flexibility Index of 0.14x as of September 2025. Free cash flow of $3.72 Million (operating CF $3.69 Million minus capex $24.00K) represents 0% of total liabilities ($27.46 Million). Check cash flow reinvestment rate of Niagen Bioscience, Inc. to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Niagen Bioscience, Inc. Financial Flexibility Index (2007–2024)
Historical Financial Flexibility Index trend for Niagen Bioscience, Inc. across 18 annual periods. For the full cash flow conversion analysis, see NAGE operating cash flow.
Annual Financial Flexibility Index for Niagen Bioscience, Inc. (2007–2024)
Year-by-year free cash flow to debt coverage for Niagen Bioscience, Inc.. Explore how well can Niagen Bioscience, Inc. service its debt to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.55x | $12.27 Million | $12.11 Million | $22.18 Million | ▲ +101.8% |
| 2023 | 0.27x | $7.26 Million | $7.12 Million | $26.51 Million | ▲ +147.1% |
| 2022 | -0.58x | $-14.76 Million | $-15.10 Million | $25.39 Million | ▲ +36.1% |
| 2021 | -0.91x | $-23.75 Million | $-24.16 Million | $26.11 Million | ▼ -90.8% |
| 2020 | -0.48x | $-10.46 Million | $-10.60 Million | $21.93 Million | ▲ +52.0% |
| 2019 | -0.99x | $-19.69 Million | $-20.44 Million | $19.80 Million | ▲ +23.1% |
| 2018 | -1.29x | $-19.46 Million | $-20.91 Million | $15.05 Million | ▼ -35.9% |
| 2017 | -0.95x | $-8.45 Million | $-9.80 Million | $8.89 Million | ▼ -667.3% |
| 2016 | -0.12x | $-1.21 Million | $-2.94 Million | $9.78 Million | ▼ -14.1% |
| 2015 | -0.11x | $-1.46 Million | $-2.11 Million | $13.47 Million | ▲ +64.9% |
| 2014 | -0.31x | $-2.33 Million | $-2.58 Million | $7.52 Million | ▲ +72.0% |
| 2013 | -1.11x | $-3.68 Million | $-3.91 Million | $3.32 Million | ▲ +44.4% |
| 2012 | -1.99x | $-10.04 Million | $-10.12 Million | $5.04 Million | ▼ -88.4% |
| 2011 | -1.06x | $-3.92 Million | $-4.10 Million | $3.71 Million | ▲ +32.5% |
| 2010 | -1.57x | $-2.46 Million | $-2.66 Million | $1.57 Million | ▼ -1763.9% |
| 2009 | -0.08x | $-211.69K | $-396.17K | $2.52 Million | ▲ +86.2% |
| 2008 | -0.61x | $-1.43 Million | $-1.92 Million | $2.33 Million | ▲ +99.4% |
| 2007 | -96.21x | $-38.48K | $-38.48K | $400.00 | — |